🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

Recruitingn/aAges 18 Years - anyAllHerlev and Gentofte Hospital
NCT05184400 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Histological or cytological diagnosis of BTC * Patients referred for treatment of BTC * Signed informed consent Exclusion Criteria: * None
💊

What it tests

  • Not listed
📍

Where

1 site
Herlev & Gentofte Hospital
Herlev, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy